Skip to end of metadata
  • Created by Former user, last modified by Former user on Jul 28, 2021
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 21 Next »


Project Scope

This project team will create a White Paper with recommendations for listings to include in Clinical Study Reports based on shared learning from cross-industry participants, to address changes in data availability over time.

Project LeadsEmails
Mercy Navarronavarrom@gene.com 
Nancy Brucken 

nbrucken@csg-inc.com

Paula Rowley (PHUSE Project Assistant)paula@phuse.global 
Objectives & DeliverablesTimelines

White Paper providing recommendations for listings to include CSRs and submissions (if any), with a summary of example alternatives to static listings.

Public Review

Final Paper



Q12021

Q22021

Project MembersOrganisation
Anna LeathEli Lilly
Kim MusgraveAmgen
Maria DaltonGSK
Mary NilssonEli Lilly
Raj PhadtareCorvus Pharma

CURRENT STATUS Q22021

White paper went out for public review. Review period has been extended to allow for expected feedback from the FDA. Hoping to have this finalised for Q3.


  • No labels